Clinical Trial

Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a single-center, single-arm, prospective clinical trial designed to evaluate the efficacy of local excision followed by postoperative chemoradiotherapy in patients with early-stage low/ultra-low rectal cancer. The study plans to enroll 60 patients with T1-2N0M0 low/ultra-low rectal cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-22.
Trial Details
NCT Number NCT06949098
Lead Sponsor Hebei Medical University Fourth Hospital
Conditions Rectal Cancer Stage I
Enrollment 60 participants
Start Date 2025-05-15
Primary Completion 2032-03 (estimated)
Study Completion 2032-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-03